Quick Summary:
In the evolving field of neurosciences, the global optogenetics market has been making notable strides. Optogenetics, combining genetic and optical technologies, provides critical insights into individual biological functions and behavior, aiding in significant clinical discoveries. Due to its valuable applications, optogenetics is becoming integral in better understanding diseases like chronic pain, epilepsy, Parkinson's disease, and various mental health disorders, ultimately broadening medical frontiers.
There are several key trends driving the expansion of the optogenetics market. The most notable trends include the increasing prevalence of neurological disorders, advancements in neural connectivity technologies and imaging tools, and rising healthcare expenditure. The strategic collaboration between key market players, pharmaceutical companies, and governments to implement favorable policies for the development of innovative drugs also offer significant potential for market growth. Furthermore, the introduction of fiber-coupled LED implants and the increased interest in optogenetic therapeutic methodologies for its precision are greatly contributing to the market's positive outlook. Its utilization in controlling and monitoring cellular activities brings unprecedented value to the field.
This comprehensive report profiles leading players, provides analysis of key trends, offers forecasts at different levels, and classifies the market based on light equipment type, application, end user, and region. Armed with this knowledge, stakeholders can make well-informed decisions and strategise effectively for the future.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
Optogenetics Market Trends:
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global optogenetics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on light equipment type, application and end user.Breakup by Light Equipment Type:
- Light-emitting Diode (LED)
- Laser
Breakup by Application:
- Neuroscience
- Behavioral Tracking
- Retinal Disease Treatment
- Others
Breakup by End User:
- Hospitals
- Clinics
- Diagnostic
- Research
- Others
Breakup by Region:
North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HÜBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.Key Questions Answered in This Report
1. What was the size of the global optogenetics market in 2022?2. What is the expected growth rate of the global optogenetics market during 2023-2028?
3. What are the key factors driving the global optogenetics market?
4. What has been the impact of COVID-19 on the global optogenetics market?
5. What is the breakup of the global optogenetics market based on the light equipment type?
6. What is the breakup of the global optogenetics market based on the application?
7. What are the key regions in the global optogenetics market?
8. Who are the key players/companies in the global optogenetics market?
What is the estimated value of the Global Optogenetics Market?
What is the growth rate of the Global Optogenetics Market?
What is the forecasted size of the Global Optogenetics Market?
Who are the key companies in the Global Optogenetics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 134 |
| Published | May 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 38.5 Billion |
| Forecasted Market Value ( USD | $ 99.9 Billion |
| Compound Annual Growth Rate | 17.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
Companies Mentioned
- Addgene
- Coherent Inc.
- Elliot Scientific Limited
- GenSight Biologics S.A.
- HÜBNER GmbH & Co KG
- Judges Scientific plc
- Laserglow Technologies
- Noldus Information Technology
- Regenxbio Inc.
- Shanghai Laser & Optics Century Co. Ltd
- The Jackson Laboratory
- Thorlabs Inc.
Methodology
LOADING...
